Global Radiopharmaceuticals in Nuclear Medicine Market Insights, Forecast to 2028

Radiopharmaceuticals in Nuclear Medicine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Radiopharmaceuticals in Nuclear Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Diagnostic Radiopharmaceuticals

 

Therapy Radiopharmaceuticals

 

Enriched Stable Isotopes

Segment by Application

Diagnostic Application

Therapeutic Application

Research

Pharmaceutical

Other

By Company

Bracco Imaging S.P.A.

Cambridge Isotope Laboratories, Inc.

Cardinal Health, Inc.

Covidien, Plc

Eczacibasi-Monrol

Fujifilm Holdings Corporation

GE Healthcare (Subsidiary Of General Electric Company)

IBA Group

Isotec, Inc. (Sigma-Aldrich)

Lantheus Medical Imaging, Inc.

Nordion, Inc.

Ntp Radioisotopes (Pty), Ltd.

Siemens Healthcare (Subsidiary Of Siemens AG)

Taiyo Nippon Sanso Corporation

Urenco Limited

Rotem Industries, Ltd., Inc.

Australian Nuclear Association And Technology Organization (ANSTO)

Board of Radiation And Isotope Technology (BRIT)

Institute of Atomic Energy Polatom Radioisotope Centre

Institute of Isotopes Co., Ltd.

Institute Of Radioelement (IRE)

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Table of content

1 Study Coverage
1.1 Radiopharmaceuticals in Nuclear Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapy Radiopharmaceuticals
1.2.4 Enriched Stable Isotopes
1.3 Market by Application
1.3.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Estimates and Forecasts 2017-2028
2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Estimates and Forecasts 2017-2028
2.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Radiopharmaceuticals in Nuclear Medicine Sales by Region
2.4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2017-2022)
2.4.2 Global Sales Radiopharmaceuticals in Nuclear Medicine by Region (2023-2028)
2.5 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region
2.5.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2022)
2.5.2 Global Radiopharmaceuticals i

 

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Visit: https://www.24marketreports.com/
Similar Reports: 2022 Global Radiopharmaceuticals in Nuclear Medicine Industry Status and Prospects Professional Market Research Report Standard Version

Radiopharmaceuticals in Nuclear Medicine Market, Global Outlook and Forecast 2022-2028

Radiopharmaceuticals in Nuclear Medicine Market, Global Outlook and Forecast 2022-2028

Global Radiopharmaceuticals in Nuclear Medicine Market Insights and Forecast to 2028

https://www.24marketreports.com/

Related Articles

Back to top button